AX-158

N/A

Report date: 2023/02/14 20:00:43
NMEFirst In Class

Base Information

Drug NameAX-158
Drug Alias NameAX-158Artax-158
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNck adaptor protein 1 inhibitorsImmunomodulators
TargetsNck adaptor protein 1
Therapy Area/IndicationsPlaque psoriasisAutoimmune DiseasesPsoriasis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesUnited Kingdom
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesArtax Biopharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesArtax Biopharma Inc
Inactive CompaniesN/A
Active IndicationsPlaque psoriasisAutoimmune DiseasesPsoriasis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A